Other OTC - Delayed Quote • USD
RavenQuest BioMed Inc. (RVVQF)
As of March 28 at 10:28 AM EDT. Market Open.
Breakdown
TTM
Total Revenue
1,522.0440
Cost of Revenue
629.6680
Gross Profit
892.3760
Operating Expense
19,149.2440
Operating Income
-18,256.8680
Net Non Operating Interest Income Expense
-3,174.9880
Other Income Expense
-11,495.7950
Pretax Income
-32,927.6510
Net Income Common Stockholders
-32,349.6510
Diluted NI Available to Com Stockholders
-32,349.6510
Basic EPS
-0.33
Diluted EPS
-0.33
Basic Average Shares
114,235.3430
Diluted Average Shares
114,235.3430
Rent Expense Supplemental
1,007.9930
Total Expenses
19,778.9120
Interest Expense
3,174.9880
Net Interest Income
-3,174.9880
Net Income from Continuing & Discontinued Operation
-32,349.6510
Normalized Income
-20,853.8560
EBIT
-29,752.6630
EBITDA
-25,857.9900
Reconciled Cost of Revenue
629.6680
Reconciled Depreciation
3,894.6730
Net Income from Continuing Operation Net Minority Interest
-32,349.6510
Total Unusual Items Excluding Goodwill
-11,495.7950
Total Unusual Items
-11,495.7950
Normalized EBITDA
-14,362.1950
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade